- Home
- VOYA vs LNTH Comparison
VOYA vs LNTH Comparison
Compare VOYA & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOYA
- LNTH
- Stock Information
- Founded
- VOYA 1975
- LNTH 1956
- Country
- VOYA United States
- LNTH United States
- Employees
- VOYA N/A
- LNTH N/A
- Industry
- VOYA Life Insurance
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VOYA Finance
- LNTH Health Care
- Exchange
- VOYA Nasdaq
- LNTH Nasdaq
- Market Cap
- VOYA 6.7B
- LNTH 6.3B
- IPO Year
- VOYA 2013
- LNTH 2015
- Fundamental
- Price
- VOYA $67.20
- LNTH $89.29
- Analyst Decision
- VOYA Buy
- LNTH Strong Buy
- Analyst Count
- VOYA 12
- LNTH 6
- Target Price
- VOYA $85.36
- LNTH $132.67
- AVG Volume (30 Days)
- VOYA 983.5K
- LNTH 1.0M
- Earning Date
- VOYA 02-04-2025
- LNTH 11-06-2024
- Dividend Yield
- VOYA 2.68%
- LNTH N/A
- EPS Growth
- VOYA 3.27
- LNTH 304.57
- EPS
- VOYA 6.28
- LNTH 6.02
- Revenue
- VOYA $7,859,000,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- VOYA N/A
- LNTH $19.64
- Revenue Next Year
- VOYA $6.88
- LNTH $4.38
- P/E Ratio
- VOYA $10.70
- LNTH $14.83
- Revenue Growth
- VOYA 10.94
- LNTH 24.15
- 52 Week Low
- VOYA $63.11
- LNTH $50.20
- 52 Week High
- VOYA $84.30
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- VOYA 23.15
- LNTH 44.02
- Support Level
- VOYA $65.87
- LNTH $91.20
- Resistance Level
- VOYA $83.59
- LNTH $96.46
- Average True Range (ATR)
- VOYA 1.77
- LNTH 2.89
- MACD
- VOYA -1.23
- LNTH 0.54
- Stochastic Oscillator
- VOYA 7.61
- LNTH 26.33
About VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.